"There's a number of emerging modalities in the primary focal ablation space that are in trial at this time," says Kara L. Watts, MD. In this video, Kara L. Watts, MD, shares her predictions for ...

Studies reveal a connection between benign prostatic hyperplasia and erectile dysfunction, emphasizing the need for comprehensive patient management. Aquablation therapy receives a Category I CPT code ...

Panelists discuss how the management of metastatic castration-resistant prostate cancer with a homologous recombination repair (HRR) alteration involves targeted therapies, such as PARP inhibitors, to ...

Alkaline water may not effectively prevent kidney stones due to negligible impact on urinary pH and citrate levels. FDA cleared the RenaFlex ureteroscope system and Stone Clear device, enhancing ...

BCG-unresponsive NMIBC is defined by persistent or recurrent high-grade tumors or carcinoma in situ after adequate BCG therapy. This condition requires alternative therapeutic strategies or radical ...

The 2023 CUA guideline highlights the significance of specimen collection and timing in prostate cancer genetic testing. Practical strategies are provided to optimize genetic testing outcomes, ...

"We're excited about the science behind it, but we're also excited for our patients that if they can have access to this, maybe we can delay or completely avoid radical cystectomy or further ...

A panelist discusses how identifying intermediate-risk patients, managing disease heterogeneity in non–muscle-invasive bladder cancer, and addressing long-term care needs present key challenges in ...

The ASPIRE trial showed SURE's noninferiority to URS in stone-free rate for nephrolithiasis treatment. SURE demonstrated superior stone clearance and residual stone volume outcomes, unaffected by ...

The therapeutic response rate was 79% at 24 months, which is comparable to the rates seen at 6 months (78%) and 12 months (82%).

“I think there's a lot to be done and combination therapies, other drugs that can be instilled into this device. It's a bright future,” says Siamak Daneshmand, MD. In this video, Siamak Daneshmand, MD ...

The series empowers surgeons to make informed family planning decisions through education, resources, and peer networking. Research indicates female surgeons face higher pregnancy complications and ...